If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
326.40    14.20 (4.55%)
Bid:
322.40
Ask:
324.20
Spread: 1.80 (0.558%)
Market Cap: £715.04m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Update On Coronavirus Impact

12 Mar 2020 13:51

RNS Number : 9612F
Burford Capital Limited
12 March 2020
 

 

12 March 2020

 

 

BURFORD CAPITAL PROVIDES UPDATE ON CORONAVIRUS IMPACT

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and investment management firm focused on law, today releases the following announcement about its approach to the coronavirus outbreak and the timing of the disclosure of its fiscal year 2019 results.

 

Burford has closed its New York office in response to the coronavirus outbreak following a number of locally relevant data points. Both the Governor of New York and the Mayor of New York City have asked businesses to have employees work remotely, and we along with a number of our law firm clients are doing so. The US National Guard has been dispatched to a New York City suburb to contain an outbreak traced to a midtown Manhattan lawyer; one of Burford's executives' brothers is under quarantine due to that outbreak. Major US universities in our region, including Columbia, Harvard and Yale, have moved their spring terms online and asked students not to return to campus. Google, Facebook and Amazon have asked their New York employees to work remotely. Prudence suggests that we follow suit.

 

Virus notwithstanding, we remain open for business, signing two term sheets for new investments just yesterday and operating a standard full-capacity Commitment Committee calendar. Courts remain generally operational, and where delays occur, Burford often benefits economically from them. Burford is a global and geographically dispersed business built with remote operations in mind. All of our information systems are cloud-based. Our client base of lawyers is especially capable of working virtually and we are confident in our ability to keep engaging them. We do not believe that these disruptions will have any material negative impact on our business, and indeed we expect a heightened level of engagement as firms and their clients head into a potential downturn and also come to grips with the economic damage inflicted by the coronavirus. In addition, our management team is geographically dispersed and will remain so, mitigating any local impacts.

 

However, current events together with the closure of our New York office will inevitably take a toll on our finance and in-house legal teams whose work is collaborative. To illustrate the scale of US disruption, the Securities and Exchange Commission has extended issuer disclosure filing deadlines in this period by 45 days. Our finance team is predominantly based in our New York office. Moreover, we also have two employees key to our results process who have had to self-isolate at home. We also have third-party dependencies, ranging from auditors to printers to graphic designers, who are also affected by the coronavirus.

 

Thus, we anticipate a delay in the release of our fiscal year 2019 results. At present, we anticipate that delay to be two or three weeks, and we will announce a firm date for our results as soon as we are able; as things stand presently, we certainly do not expect the delay to extend beyond Easter. We are also not offering an in-person investor roadshow this year. The progress we have made to date in our year-end process affirms our view that we expect to release financial statements that are consistent with the guidance provided in our 3 February 2020 trading update. Given the present extraordinary market conditions, we also remind investors of our liquidity policy. Irrespective of the market or economic cycle, Burford has historically maintained a significant amount of liquidity in the form of cash on its balance sheet and that continues to be the case today.

 

Christopher Bogart, Burford's CEO, commented:

 

"We regret the delay in the release of our 2019 results, but these are unprecedented circumstances and the health and safety of our team is our first priority. This is a rapidly evolving situation. Burford is acting on strong medical advice and following the lead of a number of other respected firms."

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

 

About Burford Capital

Burford Capital is the leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUBCWUPUGWP
Date   Source Headline
2nd Jul 202611:00 amRNSIssue of Equity in Connection with LTIP
25th Jun 202611:00 amRNSIssue of Equity in Connection with NED Plan Grants
17th Jun 202612:00 pmRNSDirector/PDMR Shareholding & Equity Issue re DCP
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.